Medicilon: Innovating Globally at CMC-China Expo 2025

Preclinical CRO

CMC-China Expo 2025 August 1, 2025–The CMC-China Expo 2025, themed “Breakthrough, Symbiosis, and Globalization,” opened today at the Suzhou International Expo Centre. The conference gathers biopharmaceutical experts and executives to foster collaboration on innovative technologies and explore future industry development, addressing key topics to drive high-quality growth in the biopharmaceutical sector. Top 20 Preclinical CROs […]

Search Medicilon

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Preclinical CRO

Medicilon’s Formulation CDMO Platform Advances Taiji Group’s Next-Generation RNA Polymerase Inhibitor DSC158A Tablets to Clinical Stage

Preclinical CRO

TPD CN-US Dual Filing Milestone: Medicilon’s One-Stop Platform Helps Gluetacs Secure Dual Approval for GT818, a First-in-Class RSK Degrader

Contact Medicilon

Name(Required)
Address(Required)